(((S)-1-(2-(L-seryl)hydrazinyl)-4-amino-1,4-dioxobutan-2-yl)carbamoyl)-L-threonine

ID: ALA4438020

Chembl Id: CHEMBL4438020

PubChem CID: 155512818

Max Phase: Preclinical

Molecular Formula: C12H22N6O8

Molecular Weight: 378.34

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@H](O)[C@H](NC(=O)N[C@@H](CC(N)=O)C(=O)NNC(=O)[C@@H](N)CO)C(=O)O

Standard InChI:  InChI=1S/C12H22N6O8/c1-4(20)8(11(24)25)16-12(26)15-6(2-7(14)21)10(23)18-17-9(22)5(13)3-19/h4-6,8,19-20H,2-3,13H2,1H3,(H2,14,21)(H,17,22)(H,18,23)(H,24,25)(H2,15,16,26)/t4-,5+,6+,8+/m1/s1

Standard InChI Key:  NJASRIPIAOCWFU-LKXGYXEUSA-N

Alternative Forms

  1. Parent:

    ALA4438020

    ---

Associated Targets(Human)

PDCD1 Tclin Programmed cell death protein 1/Programmed cell death 1 ligand 1 (1367 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CD274 Tclin Programmed cell death 1 ligand 1 (299 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDCD1 Tclin Programmed cell death protein 1 (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDCD1LG2 Tchem Programmed cell death 1 ligand 2 (3 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cd274 Programmed cell death 1 ligand 1 (33 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pdcd1lg2 Programmed cell death 1 ligand 2 (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Splenocyte (1641 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CT26 (928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 378.34Molecular Weight (Monoisotopic): 378.1499AlogP: -5.17#Rotatable Bonds: 9
Polar Surface Area: 246.20Molecular Species: ACIDHBA: 8HBD: 9
#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 11#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.54CX Basic pKa: 7.41CX LogP: -7.97CX LogD: -8.23
Aromatic Rings: Heavy Atoms: 26QED Weighted: 0.17Np Likeness Score: -0.09

References

1. Blevins DJ, Hanley R, Bolduc T, Powell DA, Gignac M, Walker K, Carr MD, Hof F, Wulff JE..  (2019)  In Vitro Assessment of Putative PD-1/PD-L1 Inhibitors: Suggestions of an Alternative Mode of Action.,  10  (8): [PMID:31413804] [10.1021/acsmedchemlett.9b00221]
2. Wang T, Wu X, Guo C, Zhang K, Xu J, Li Z, Jiang S..  (2019)  Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway.,  62  (4): [PMID:30247903] [10.1021/acs.jmedchem.8b00990]
3. Chen T, Li Q, Liu Z, Chen Y, Feng F, Sun H..  (2019)  Peptide-based and small synthetic molecule inhibitors on PD-1/PD-L1 pathway: A new choice for immunotherapy?,  161  [PMID:30384043] [10.1016/j.ejmech.2018.10.044]

Source